For this purpose, we analyzed AD core biomarkers (i.e., Aβ 42, Aβ 42/40 ratio, tTau, and pTau), as well as NF-L and Ng, which are widely considered markers of neurodegeneration and synaptic dysfunction, respectively. The gene discussed is NEFL; the disease is Alzheimer disease.